SC
ZYME icon

Shay Capital’s Zymeworks ZYME Stock Holding History

Shay Capital’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-11,339
Closed -$118K – 479
2023
Q4 		$118K Sell
11,339
-60,854
-84% -$485K 0.02% 228
2023
Q3 		$458K Buy
72,193
+58,217
+417% +$430K 0.06% 173
2023
Q2 		$121K Buy
+13,976
New +$125K 0.02% 323

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Shay Capital's ZYME Position: Q1 2024 in Review

Shay Capital sold out of Zymeworks (ZYME) in Q1 2024, closing a stake of 11,339 shares — an estimated $118K sold.

Shay Capital first reported a position in ZYME in Q2 2023 and held it in 3 quarters. The position peaked at $458K in Q3 2023. 171 funds tracked by Wall St. Rank hold ZYME as of Q1 2024.

  • Shay Capital reported no remaining Zymeworks position as of Q1 2024 after selling out during the quarter.
  • Shay Capital sold 11,339 Zymeworks shares in Q1 2024, an estimated $118K.
  • Shay Capital first reported a position in Zymeworks in Q2 2023 and held it in 3 quarters.
  • Shay Capital's Zymeworks position peaked at $458K in Q3 2023.
  • 171 funds tracked by Wall St. Rank held Zymeworks as of Q1 2024.

Based on Shay Capital's 13F filing for Q1 2024, filed 15 May 2024.